B

Bicara Therapeutics Inc
NASDAQ:BCAX

Watchlist Manager
Bicara Therapeutics Inc
NASDAQ:BCAX
Watchlist
Price: 18.72 USD -0.9%
Market Cap: 1B USD

Wall Street
Price Targets

BCAX Price Targets Summary
Bicara Therapeutics Inc

Wall Street analysts forecast BCAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCAX is 33.22 USD with a low forecast of 11.11 USD and a high forecast of 50.4 USD.

Lowest
Price Target
11.11 USD
41% Downside
Average
Price Target
33.22 USD
77% Upside
Highest
Price Target
50.4 USD
169% Upside
Bicara Therapeutics Inc Competitors:
Price Targets
PRQR
ProQR Therapeutics NV
329% Upside
BIOCON
Biocon Ltd
15% Upside
PEB
Pacific Edge Ltd
19% Downside
CHRS
Coherus BioSciences Inc
295% Upside
MRSN
Mersana Therapeutics Inc
20% Upside
ATRA
Atara Biotherapeutics Inc
11% Upside
PHARM
Pharming Group NV
37% Upside
BIIB
Biogen Inc
7% Upside

Revenue
Forecast

Revenue Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCAX's stock price target?
Price Target
33.22 USD

According to Wall Street analysts, the average 1-year price target for BCAX is 33.22 USD with a low forecast of 11.11 USD and a high forecast of 50.4 USD.

Back to Top